Correlation Between Celldex Therapeutics and Morningstar Unconstrained

Can any of the company-specific risk be diversified away by investing in both Celldex Therapeutics and Morningstar Unconstrained at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celldex Therapeutics and Morningstar Unconstrained into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Celldex Therapeutics and Morningstar Unconstrained Allocation, you can compare the effects of market volatilities on Celldex Therapeutics and Morningstar Unconstrained and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celldex Therapeutics with a short position of Morningstar Unconstrained. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celldex Therapeutics and Morningstar Unconstrained.

Diversification Opportunities for Celldex Therapeutics and Morningstar Unconstrained

0.42

Correlation Coefficient

Celldex Therapeutics  Morningstar Unconstrained

Very weak diversification

The 3 months correlation between Celldex and Morningstar is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and Morningstar Unconstrained Allo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morningstar Unconstrained and Celldex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celldex Therapeutics are associated (or correlated) with Morningstar Unconstrained. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morningstar Unconstrained has no effect on the direction of Celldex Therapeutics i.e., Celldex Therapeutics and Morningstar Unconstrained go up and down completely randomly.

Pair Corralation between Celldex Therapeutics and Morningstar Unconstrained

Given the investment horizon of 90 days Celldex Therapeutics is expected to under-perform the Morningstar Unconstrained. In addition to that, Celldex Therapeutics is 3.5 times more volatile than Morningstar Unconstrained Allocation. It trades about -0.13 of its total potential returns per unit of risk. Morningstar Unconstrained Allocation is currently generating about -0.17 per unit of volatility. If you would invest  1,192  in Morningstar Unconstrained Allocation on September 29, 2024 and sell it today you would lose (116.00) from holding Morningstar Unconstrained Allocation or give up 9.73% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Celldex Therapeutics  vs.  Morningstar Unconstrained Allo

Celldex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celldex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Morningstar Unconstrained

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Morningstar Unconstrained Allocation has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Celldex Therapeutics and Morningstar Unconstrained

The main advantage of trading using opposite Celldex Therapeutics and Morningstar Unconstrained positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celldex Therapeutics position performs unexpectedly, Morningstar Unconstrained can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morningstar Unconstrained will offset losses from the drop in Morningstar Unconstrained's long position.

The idea behind Celldex Therapeutics and Morningstar Unconstrained Allocation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.